Established in 1983 in Milan, Guna is an Italian company that specializes in producing and distributing low-dose and biological medicine. Since 1989, Guna has been authorized to distribute pharmaceutical products. In 2017, Guna had a market share of 25% and a turnover of over 61 million Euro.
Guna is notable for researching, designing and developing top-quality low-dose medicines and their innovative creation of food supplements, medical devices, Bach Flowers and cosmetics. Guna’s products are available in over 30 countries.
Guna has over 70 products that are FDA listed and regulated and sold by Guna Inc., a subsidiary of Guna located in Pennsylvania, USA.
Guna opened their production facility in 2008 in an area covering 65,000 square feet and follows strict international guidelines set by Good Manufacturing Practices (GMP) and production procedures are approved under ISO 9001:2008 and ISO 13485:2012 for medical devices.
Developed by Guna, SKA (Sequential Kinetic Activation) is a pharmaceutical technique that support efficacy without side effects for their products. When SKA technology is applied, lower doses of biological molecules can be just as effective as the higher doses.